NEW YORK, May 19, 2017 /PRNewswire/ --
This morning, Stock-Callers.com revisits the Services sector, which is an umbrella term that describes any job that produces intangible value or goods. Equities lined up for evaluation today are: Rite Aid Corp. (NYSE: RAD), Cardinal Health Inc. (NYSE: CAH), AmerisourceBergen Corp. (NYSE: ABC), and McKesson Corp. (NYSE: MCK). You can access our complimentary research reports on these stocks now at:
Shares in Camp Hill, Pennsylvania headquartered Rite Aid Corp. saw a decline of 6.54%, ending Thursday's trading session at $3.43. The stock recorded a trading volume of 30.35 million shares, which was higher than its three months average volume of 18.79 million shares. The Company's shares are trading 20.86% below their 50-day moving average. Moreover, shares of Rite Aid, which through its subsidiaries, operates a chain of retail drugstores in the US, have a Relative Strength Index (RSI) of 30.60.
On April 25th, 2017, research firm Guggenheim downgraded the Company's stock rating from 'Buy' to 'Neutral'.
On April 25th, 2017, Rite Aid reported operating results for its 14-week fourth quarter and 53-week fiscal year ended March 04th, 2017. For Q4 FY17, revenues were $8.5 billion, net loss was $21.1 million, adjusted net loss was $3.2 million, and adjusted EBITDA was $264.3 million. For the full year, revenues were $32.8 billion, net income was $4.1 million, adjusted net income was $66.8 million, and adjusted EBITDA was $1,137.1 million. Visit us today and download your complete report on RAD for free at:
Dublin, Ohio headquartered Cardinal Health Inc.'s stock rose 0.82%, closing the day at $72.19 with a total trading volume of 2.07 million shares. The Company's shares have advanced 0.86% since the start of this year. The stock is trading 4.78% below its 200-day moving average. Additionally, shares of Cardinal Health, which operates as a healthcare services and products company worldwide, have an RSI of 37.29.
On May 03rd, 2017, the Cardinal Health's Board of Directors approved a 3% increase in the Company's quarterly dividend from $0.4489 per share to $0.4624 per share. The dividend will be payable on July 15th, 2017, to shareholders of record on July 03rd, 2017.
On May 17th, 2017, research firm Jefferies initiated a 'Hold' rating on the Company's stock, with a target price of $77 per share. The complimentary research report on CAH can be accessed at:
On Thursday, shares in Chesterbrook, Pennsylvania headquartered AmerisourceBergen Corp. recorded a trading volume of 1.15 million shares. The stock ended the day 0.48% higher at $86.69. The Company's shares have advanced 5.91% in the past month and 11.32% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 0.41% and 3.59%, respectively. Furthermore, shares of AmerisourceBergen, which sources and distributes pharmaceutical products in the US and internationally, have an RSI of 53.04.
On May 09th, 2017, AmerisourceBergen's Board of Directors declared a quarterly dividend of $0.365 per common share, payable on June 05th, 2017, to stockholders of record at the close of business on May 22nd, 2017.
On May 17th, 2017, research firm Jefferies initiated a 'Hold' rating on the Company's stock, with a target price of $95 per share. Register for free on Stock-Callers.com and download the PDF research report on ABC at:
San Francisco, California headquartered McKesson Corp.'s stock dropped 0.42%, finishing yesterday's session at $141.44. A total volume of 1.99 million shares was traded, which was above their three months average volume of 1.56 million shares. The Company's shares have advanced 3.93% in the last one month and 0.89% on an YTD basis. The stock is trading below its 50-day moving average by 1.66%. Additionally, shares of McKesson, which operates as a pharmaceutical distribution services and information technology company in the US and internationally, have an RSI of 47.99.
On May 17th, 2017, research firm Jefferies resumed its 'Hold' rating on the Company's stock, with a target price of $153 per share. Get free access to your research report on MCK at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA